Elevated Circulating Homocysteine and High-Sensitivity C-reactive Protein Jointly Predicts Post-Stroke Depression among Chinese Patients with Acute Ischemic Stroke

Jieyun Yin,Chongke Zhong,Zhengbao Zhu,Xiaoqing Bu,Tan Xu,Libing Guo,Xuemei Wang,Jintao Zhang,Yong Cui,Dong Li,Jianhui Zhang,Zhong Ju,Chung-Shiuan Chen,Jing Chen,Yonghong Zhang,Jiang He
DOI: https://doi.org/10.1016/j.cca.2018.01.011
IF: 6.314
2018-01-01
Clinica Chimica Acta
Abstract:Background: Homocysteine (HCY) and high sensitivity C reactive protein (hs-CRP) were suggested to be involved in post-stroke depression (PSD), which is a frequent mood disorder after stroke. However, the combined effect of HCY and hs-CRP on PSD remains unclear. Methods: A total of 598 acute ischemic stroke patients from 7 of 26 centers participating in the China Antihypertensive Trial in Acute Ischemic Stroke with HCY or hs-CRP measurements were included in this analysis. PSD status was evaluated by 24-item Hamilton Depression Rating Scale at 3 months after stroke. Results: Two hundred and forty-one (40.30%) participants were considered as PSD. HCY and hs-CRP levels were not significantly different between PSD and non-PSD patients. Interesting, in a maximally adjusted model, the odds ratio (95% confidence interval) of PSD was 1.90 (1.18-3.06) for coexistence of HCY >= 14.65 mu mol/l and hs-CRP >= 1.90 mg/l compared with the other levels (HCY < 14.65 mu mol/l and/or hs-CRP < 1.90 mg/l). Adding combination of HCY and hs-CRP to a model containing conventional risk factors could significantly improve risk reclassification for PSD. Conclusions: Coexistence of both higher HCY and higher hs-CRP in the acute phase of ischemic stroke were associated with subsequent PSD, independently of established conventional risk factors.
What problem does this paper attempt to address?